antibody phage display

IRBM is a preclinical drug discovery organization based in Rome, Italy, conducting small molecule, peptide and antibody programs from target validation through to a preclinical candidate, either as a full integrated program or as a single capability for clients. Its scientists have contributed to three approved drugs and delivered more than thirty preclinical candidates to partners.

Read more

ADMEassay developmentBioinformaticsbiophysical characterizationcompound managementcomputational chemistryDMPKfunctional genomicshigh-content screeninghigh throughput screeningin vivo pharmacologymedicinal chemistrymRNA displayNMRpeptide chemistrypeptide phage displayprotein productionstructural biologysynthetic chemistry